Y.D. More Investments Ltd Sells 194 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Y.D. More Investments Ltd trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 33.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 385 shares of the financial services provider’s stock after selling 194 shares during the quarter. Y.D. More Investments Ltd’s holdings in iShares Biotechnology ETF were worth $51,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $29,000. Highline Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $30,000. HHM Wealth Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $34,000. Finally, Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $36,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 2.5 %

NASDAQ:IBB opened at $142.33 on Thursday. The stock’s fifty day moving average price is $136.31 and its two-hundred day moving average price is $141.47. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.